In light of this and the fact that TCF4 is an established EMT regulator (Sobrado et al., 2009), it is tempting to speculate that dysregulation of TCF4's role within this pathway may contribute, in part, to the pathophysiology of CTG18.1 expansion-mediated FECD. Here, TCF4 is linked to Fuchs endothelial corneal dystrophy.